REBECCA BAKER: Open Payments
NPI 1730418385 · ALAMO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 58 payments from 15 companies in 2025. Trend: 2023 $614 · 2024 $1,308 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $225 |
| Otsuka America Pharmaceutical, Inc. | 11 | $216 |
| ABBVIE INC. | 10 | $178 |
| AstraZeneca Pharmaceuticals LP | 6 | $159 |
| Lilly USA, LLC | 6 | $88 |
| GlaxoSmithKline, LLC. | 4 | $88 |
| PFIZER INC. | 4 | $72 |
| Abbott Laboratories | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Neurelis, Inc. | 1 | $22 |
Products named: REXULTI, Ozempic, MOUNJARO, TRELEGY ELLIPTA, Wegovy, QULIPTA, FARXIGA, VRAYLAR.
Industry payments across TN — which companies pay providers there.
